Summary
Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exact Sciences Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Exact Sciences Corp Company Overview 5
Exact Sciences Corp Company Snapshot 5
Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Exact Sciences Corp – Pipeline Analysis Overview 7
Business Description 7
Exact Sciences Corp - Key Facts 7
Exact Sciences Corp - Major Products and Services 8
Exact Sciences Corp Pipeline Products by Development Stage 9
Exact Sciences Corp Pipeline Products Overview 11
Blood-based Liver Cancer Test 11
Blood-based Liver Cancer Test Product Overview 11
Blood-based Lung Cancer Screening Test 12
Blood-based Lung Cancer Screening Test Product Overview 12
Diagnostic Assay - Esophageal Cancer 13
Diagnostic Assay - Esophageal Cancer Product Overview 13
Diagnostic Assay - Pancreatic Cancer 14
Diagnostic Assay - Pancreatic Cancer Product Overview 14
Diagnostic Test - Breast Cancer 15
Diagnostic Test - Breast Cancer Product Overview 15
Diagnostic Test - Lung Cancer 16
Diagnostic Test - Lung Cancer Product Overview 16
Diagnostic Test - Prostate Cancer 17
Diagnostic Test - Prostate Cancer Product Overview 17
DNA Biomarkers - Hepatocellular Carcinoma 18
DNA Biomarkers - Hepatocellular Carcinoma Product Overview 18
DNA Integrity Assay 19
DNA Integrity Assay Product Overview 19
PreGen-Plus 20
PreGen-Plus Product Overview 20
Exact Sciences Corp - Key Competitors 21
Exact Sciences Corp - Key Employees 22
Exact Sciences Corp - Key Employee Biographies 24
Exact Sciences Corp - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Exact Sciences Corp, Recent Developments 26
Jun 19, 2018: Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer 26
Jun 05, 2018: Mayo Clinic researchers take a step closer to developing a DNA test for liver cancer 27
Jun 05, 2018: Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma 27
May 30, 2018: Exact Sciences Applauds American Cancer Society''s Updated Colorectal Cancer Screening Guidelines to Include People Age 45-49 28
May 03, 2018: Vince Lombardi Cancer Foundation and Exact Sciences Team Up to Fight Colon Cancer 29
Apr 26, 2018: Cologuard revenue and completed tests increased 87 percent to $90.3 million and 186,000 30
Mar 20, 2018: Mark Stenhouse to join Exact Sciences as President, Cologuard 30
Mar 06, 2018: Mayo Clinic's Dr. Paul Limburg to join Exact Sciences medical leadership 31
Mar 01, 2018: Jerry Kelly Issues Cologuard Challenge, Urging Fellow PGA TOUR Champions Players to Get Screened for Colon Cancer 32
Feb 26, 2018: More than 1 Million Screened for Colorectal Cancer with Cologuard 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Exact Sciences Corp Pipeline Products by Equipment Type 6
Exact Sciences Corp Pipeline Products by Indication 6
Exact Sciences Corp, Key Facts 7
Exact Sciences Corp, Major Products and Services 8
Exact Sciences Corp Number of Pipeline Products by Development Stage 9
Exact Sciences Corp Pipeline Products Summary by Development Stage 10
Blood-based Liver Cancer Test - Product Status 11
Blood-based Liver Cancer Test - Product Description 11
Blood-based Lung Cancer Screening Test - Product Status 12
Blood-based Lung Cancer Screening Test - Product Description 12
Diagnostic Assay - Esophageal Cancer - Product Status 13
Diagnostic Assay - Esophageal Cancer - Product Description 13
Diagnostic Assay - Pancreatic Cancer - Product Status 14
Diagnostic Assay - Pancreatic Cancer - Product Description 14
Diagnostic Test - Breast Cancer - Product Status 15
Diagnostic Test - Breast Cancer - Product Description 15
Diagnostic Test - Lung Cancer - Product Status 16
Diagnostic Test - Lung Cancer - Product Description 16
Diagnostic Test - Prostate Cancer - Product Status 17
Diagnostic Test - Prostate Cancer - Product Description 17
DNA Biomarkers - Hepatocellular Carcinoma - Product Status 18
DNA Biomarkers - Hepatocellular Carcinoma - Product Description 18
DNA Integrity Assay - Product Status 19
DNA Integrity Assay - Product Description 19
PreGen-Plus - Product Status 20
PreGen-Plus - Product Description 20
Exact Sciences Corp, Key Employees 22
Exact Sciences Corp, Key Employee Biographies 24
Exact Sciences Corp, Subsidiaries 25
Glossary 36
List of Figures
Exact Sciences Corp Pipeline Products by Equipment Type 6
Exact Sciences Corp Pipeline Products by Development Stage 9
